These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24106933)

  • 21. Two-year outcomes after first- or second-generation drug-eluting stent implantation in patients with in-stent restenosis. A PRODIGY trial substudy.
    Campo G; Punzetti S; Malagù M; Ferrari R; Valgimigli M
    Int J Cardiol; 2014 May; 173(2):343-5. PubMed ID: 24680246
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical value of inflammatory biomarkers after stent implantation].
    Niccoli G; Montone RA; Ferrante G; Minelli S; Crea F
    G Ital Cardiol (Rome); 2011 Oct; 12(10):635-44. PubMed ID: 21947106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug-eluting stents for the treatment of coronary artery disease: NICE technology appraisal guidance.
    Messori A; Trippoli S
    Heart; 2009 May; 95(10):847. PubMed ID: 19401286
    [No Abstract]   [Full Text] [Related]  

  • 24. Treating bifurcations with drug-eluting balloon: an indication not ready for prime time.
    Belardi JA; Albertal M
    Catheter Cardiovasc Interv; 2012 Dec; 80(7):1147-8. PubMed ID: 23225652
    [No Abstract]   [Full Text] [Related]  

  • 25. Casebook: chest pain.
    Yang W; Wragg A; Timmis A
    Practitioner; 2002 Jun; 246(1635):385-9, 392, 395 passim. PubMed ID: 12073697
    [No Abstract]   [Full Text] [Related]  

  • 26. Everolimus-Eluting Stents in Patients With Bare-Metal and Drug-Eluting In-Stent Restenosis: Results From a Patient-Level Pooled Analysis of the RIBS IV and V Trials.
    Alfonso F; Pérez-Vizcayno MJ; García Del Blanco B; García-Touchard A; López-Mínguez JR; Masotti M; Zueco J; Melgares R; Mainar V; Moreno R; Domínguez A; Sanchís J; Bethencourt A; Moreu J; Cequier A; Martí V; Otaegui I; Bastante T; Gonzalo N; Jiménez-Quevedo P; Cárdenas A; Fernández C;
    Circ Cardiovasc Interv; 2016 Jul; 9(7):. PubMed ID: 27412868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Efficacy and safety of implantation of multiple drug-eluting stents].
    Fu Q; Li ZL; Wu HC
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jan; 28(1):110-2. PubMed ID: 18227039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Everolimus-eluting stents in interventional cardiology.
    Townsend JC; Rideout P; Steinberg DH
    Vasc Health Risk Manag; 2012; 8():393-404. PubMed ID: 22910420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the Efficacy of Paclitaxel-Eluting Balloon Catheters and Everolimus-Eluting Stents in the Treatment of Coronary In-Stent Restenosis: The Treatment of In-Stent Restenosis Study.
    Pleva L; Kukla P; Kusnierova P; Zapletalova J; Hlinomaz O
    Circ Cardiovasc Interv; 2016 Apr; 9(4):e003316. PubMed ID: 27069104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Second-generation drug-eluting stents versus drug-coated balloons for the treatment of coronary in-stent restenosis: A systematic review and meta-analysis.
    Kokkinidis DG; Prouse AF; Avner SJ; Lee JM; Waldo SW; Armstrong EJ
    Catheter Cardiovasc Interv; 2018 Aug; 92(2):285-299. PubMed ID: 29024274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Drug-eluting coronary stents].
    Zeus T; Kelm M; Nitschmann S
    Internist (Berl); 2014 Jan; 55(1):103-6. PubMed ID: 24399477
    [No Abstract]   [Full Text] [Related]  

  • 32. 18-Year Follow-Up After Coronary Stenting for Left Main Coronary Artery Lesions.
    Bai J; Dong Z; Pan L; Xia X; Zhang B
    Int Heart J; 2020 Sep; 61(5):1041-1043. PubMed ID: 32879262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Drug-eluting stents in multivessel coronary artery disease: Was one of the important fortresses of surgery conquered?].
    Okmen AS; Okmen E
    Anadolu Kardiyol Derg; 2009 Aug; 9(4):325-30. PubMed ID: 19666436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Everolimus-eluting versus paclitaxel-eluting stents.
    Dawkins KD
    Lancet; 2010 Apr; 375(9721):1160-1; author reply 1161-2. PubMed ID: 20362807
    [No Abstract]   [Full Text] [Related]  

  • 35. Angiographic outcomes with biodegradable polymer and permanent polymer drug-eluting stents.
    Kufner S; Massberg S; Dommasch M; Byrne RA; Tiroch K; Ranftl S; Fusaro M; Schömig A; Kastrati A; Mehilli J;
    Catheter Cardiovasc Interv; 2011 Aug; 78(2):161-6. PubMed ID: 21400652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Difference in statin effects on neointimal coverage after implantation of drug-eluting stents.
    Yamamoto H; Ikuta S; Kobuke K; Yasuda M; Ikeda T; Yamaji K; Ueno M; Iwanaga Y; Miyazaki S
    Coron Artery Dis; 2014 Jun; 25(4):290-5. PubMed ID: 24614628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-stent restenosis of bifurcation lesions: experience with drug-eluting balloons.
    Sergie Z; Dangas GD
    Catheter Cardiovasc Interv; 2012 Feb; 79(3):397-8. PubMed ID: 22328233
    [No Abstract]   [Full Text] [Related]  

  • 38. Drug-eluting stents: safe but not sufficient.
    Vogel RA
    JACC Cardiovasc Interv; 2009 Jun; 2(6):513-4. PubMed ID: 19539254
    [No Abstract]   [Full Text] [Related]  

  • 39. Recurrent restenosis after implantation of sirolimus-eluting stents in aorto-ostial lesions: successful treatment with polytetrafluoroethylene-covered stents.
    Gagnor A; Varbella F; Rubartelli P; Luceri S; Conte MR
    J Cardiovasc Med (Hagerstown); 2008 Feb; 9(2):201-4. PubMed ID: 18192816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New-Generation Drug-Eluting Stents for Left Main In-Stent Restenosis: The DELTA-2 Registry.
    Giustino G; Tanaka A; Erglis A; Morice MC; Van Mieghem NM; Meliga E; D'Ascenzo F; Stefanini GG; Capodanno D; Chieffo A;
    JACC Cardiovasc Interv; 2018 Dec; 11(23):2438-2440. PubMed ID: 30522680
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.